Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aim of the present investigation was to determine to what extent beta-lactamase producing
Haemophilus
influenzae (H.i.) and Branhamella catarrhalis (B.c.) were isolated in cases of failure of treatment of
acute otitis media
(
AOM
) with phenoxymethylpenicillin. Among children with suspected therapeutic failure referred to an ENT specialist altogether 11, 15% of those referred, fulfilled the criteria of
AOM
. Three of them were on erythromycin, 1 on ampicillin and 7 on phenoxymethylpenicillin. In 5 of the children treated with phenoxymethylpenicillin H.i. was isolated from middle ear exudate and/or the nasopharynx. All H.i. isolates were non-capsulated and beta-lactamase negative. One beta-lactamase producing B.c. was isolated from the nasopharynx in a patient with pure culture of H.i. in the ear exudate. The present investigation did not support the suggestion that beta-lactamase producing H.i. or B.c. are major causative agents in therapeutic failures of
AOM
treated with phenoxymethylpenicillin and did not produce any evidence supporting a change from the recommended ampicillin esters/amoxycillin in therapeutic failures.
...
PMID:Phenoxymethylpenicillin and therapeutic failure in acute otitis media. 393 32
A total of 150 children with
acute otitis media
were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in three divided doses for ten days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or
Haemophilus
sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent
acute otitis media
with effusion, and persistent middle ear effusion were comparable in the two groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in one patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of
acute otitis media
with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent
acute otitis media
with effusion were comparable with the two regimens.
...
PMID:Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion. 403 33
We analyzed data from a 14-year longitudinal study of respiratory infections in young children to determine the relative importance of viral respiratory infection and nasopharyngeal colonization with Streptococcus pneumoniae and
Haemophilus
influenzae as factors influencing the occurrence of
acute otitis media
with effusion. The incidence of this disorder was increased in children with viral respiratory infections (average relative risk, 3.2; P less than 0.0001). Infection with respiratory syncytial virus, influenza virus (type A or B), and adenovirus conferred a greater risk of otitis media than did infection with parainfluenza virus, enterovirus, or rhinovirus. Colonization of the nasopharynx with Str. pneumoniae or H. influenzae had a lesser effect on the incidence of the disease (average relative risk; 1.5; P less than 0.01). Infections with the viruses more closely associated with
acute otitis media
(respiratory syncytial virus, adenovirus, and influenza A or B) were correlated with an increased risk of recurrent disease. Prevention of selected otitis-associated viral infections should reduce the incidence of this disease.
...
PMID:A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. 628 39
The efficacy of sulbactam sodium (CP45,899-2) was investigated using the chinchilla animal model of
acute otitis media
with effusion (AOME). Both ears of 78 chinchillas were inoculated with beta-lactamase-producing nontypable
Hemophilus
influenzae. Half of the animals were treated with ampicillin sodium alone (group A) and the remaining animals received ampicillin plus sulbactam (group B). On day 14, all of the ears in group B were culture-negative whereas H influenzae was recoverable in over 70% of the effusions in group A. Similarly, the course of middle ear effusion was significantly abbreviated in group B during the two-week study period. These findings suggest that sulbactam in combination with ampicillin is effective in treating AOME secondary to infection with beta-lactamase-producing nontypable H influenzae in the chinchilla animal model.
...
PMID:Treatment of ampicillin-resistant acute otitis media in the chinchilla. 630 38
During a 2-year period nasopharyngeal specimens were taken monthly on scheduled occasions as well as at episodes of
acute otitis media
(
AOM
) from a population of children attending day-care centres. The carriage rates of pneumococci,
Haemophilus
influenzae and Branhamella catarrhalis in 26 otitis-prone (OP) children when asymptomatic and at episodes of
AOM
were compared with the carriage rates in 36 non-otitis-prone (NOP) children. Pneumococci, H. influenzae and B. catarrhalis were found as frequently in NOP as in asymptomatic OP children. At
AOM
episodes only B. catarrhalis was found significantly more often than in the scheduled cultures. The frequencies of the six most commonly isolated pneumococcal types/groups (6, 23, 19, 14, 11, 18) were similar in the cultures taken from NOP and OP children on scheduled occasions as well as in cultures taken at
AOM
episodes. In contrast to the NOP children H. influenzae and B. catarrhalis were isolated less frequently in the 3-4-year-old than in the 2-3-year-old asymptomatic OP children. Our data indicated that the presence of pneumococci, H. influenzae or B. catarrhalis in the nasopharynx does not per se increase the risk for the development of
AOM
.
...
PMID:Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. 633 72
Bacteriologic investigations were performed on 100 children with
acute otitis media
by culturing the fluid from a myringotomy site. Patients ranged in age from 7 months to 14 years, and 91 were younger than 6 years old. Bacterial isolates were yielded from cultures in 83 cases, and mixtures of two or three organisms were obtained from 15 patients. Among the total of 100 isolates, the most predominant organism was Streptococcus pneumoniae (28), followed by
Hemophilus
influenzae (26), Staphylococcus aureus (19), and Streptococcus pyogenes (six). Minimal inhibitory concentrations (MICs) of ampicillin sodium against S pneumoniae and H influenzae were 0.016 to 0.032 and 0.25 to 0.5 mg/L, respectively. None of the strains of H influenzae were resistant to ampicillin. The MICs of dicloxacillin sodium, cephalexin monohydrate, cefaclor, and erythromycin to H influenzae were 8 to 32, 8 to 16, 2 to 8, and 2 to 8 mg/L, respectively. The preferred drug for
acute otitis media
would be ampicillin in Japan, but we have to consider antistaphylococcal antibiotics for the patients who do not respond to 48 hours of treatment.
...
PMID:Bacteriology of acute otitis media in Japanese children. 633 90
A double-blind study of 240 pediatric outpatients with
acute otitis media
demonstrated that cyclacillin, administered three times a day for ten days, is as effective as and better tolerated than a similar regimen of amoxicillin. Clinical success was achieved in 96% of the children treated with each drug, and the bacteriologic cure rate was 98% in each treatment group. Only three of the 119 children (2.5%) treated with cyclacillin had drug-related diarrhea, in contrast to 17/121 children (14%) treated with amoxicillin (P less than .01). This greater tolerance for cyclacillin may be due to its more effective and rapid absorption in the upper gastrointestinal tract. The results are discussed in terms of the low incidence of resistant strains of
Haemophilus
influenzae and the advantages of cyclacillin as the first-line treatment for
acute otitis media
.
...
PMID:Cyclacillin versus amoxicillin as treatment for acute otitis media. 633 65
Optimal antimicrobial therapy of
acute otitis media
with effusion in early infancy is controversial. We studied the efficacy of cefaclor and amoxicillin in the treatment of 40 nonconsecutive infants less than 3 months of age in a double blind comparative trial. Infants were randomly assigned to receive either oral amoxicillin or cefaclor in a dosage of 40 mg/kg/day divided into 3 doses for 10 days. Clinical responses and adverse drug effects were evaluated at 48 to 72 hours, 5 to 7 days, 2 weeks and 3 weeks. Pathogenic bacteria isolated from ear aspirates in 24 cases included Streptococcus pneumoniae (14),
Haemophilus
influenzae type b (5), H. influenzae nontypeable (3), Staphylococcus aureus (4), Branhamella sp. (2), and Streptococcus pyogenes (1). Nonpathogenic bacteria isolated in 14 cases included Streptococcus epidermidis, diphtheroids and Streptococcus viridans. Two aspirates were sterile. A satisfactory clinical response was achieved in 15 of 21 cases (71%) treated with amoxicillin and 14 of 19 cases (74%) treated with cefaclor. We conclude that amoxicillin and cefaclor are comparable in efficacy for the therapy of
acute otitis media
with effusion in early infancy.
...
PMID:A controlled trial of cefaclor versus amoxicillin for treatment of acute otitis media in early infancy. 634 79
Middle ear effusion specimens were obtained from 31 children with recurrent episodes of
acute otitis media
. Of 75 total specimens 28 were obtained from children during chemoprophylaxis with sulfisoxazole. A single organism was isolated in 65 of 70 instances. Beta-lactamase was produced from Gram-negative organisms in 11 instances, and penicillin resistance from Streptococcus pneumoniae occurred in one instance.
Haemophilus
influenzae predominated during prophylaxis; S. pneumoniae predominated without it. Serotyping and biotyping were performed on 28 isolates from 8 children with consecutive episodes. In 17 instances the infecting organism was the same species but seven of these strains differed in serotype or biotype. The average number of weeks between onset of recurrence in children with homologous strains was shorter (2.6 weeks) than in the children from whom heterologous strains were found (5.7 weeks). Three media were evaluated for efficacy in 32 episodes, and direct plating resulted in the highest rate of recovery.
...
PMID:The bacteriology of recurrent otitis media and the effect of sulfisoxazole chemoprophylaxis. 636 70
A randomized clinical trial compared cefaclor and amoxicillin for the treatment of
acute otitis media
(
AOM
). Twenty-four (77%) of the 31 examined patients treated with cefaclor and 25 (83%) of the 30 examined patients treated with amoxicillin had resolution of signs and symptoms after completing a ten- to 14-day course of the antibiotic. Patients who had bilateral
AOM
, serous or mucoid middle ear effusion,
Hemophilus
influenzae cultured from effusion, or more than five previous otitis media episodes, or who were 3 years of age or younger were more likely to fail treatment.
Hemophilus
influenzae isolated from effusion were significantly less susceptible to cefaclor than amoxicillin, but none of the 12 treatment failures were caused by antibiotic-resistant infections. Eight (36%) of the 22 patients who recovered after treatment and were reexamined one to three weeks later experienced recurrent
AOM
. Ear-specific, as well as patient-specific, analyses showed no significant differences between cefaclor and amoxicillin.
...
PMID:Cefaclor v amoxicillin in treatment of acute otitis media. 636 32
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>